Victims of asbestos-related cancer have enough concerns without having to worry about access to anti-mesothelioma drugs, says Joseph W. Belluck of New York’s Belluck & Fox, LLP.New York, NY (PRWEB) November 21, 2011 Recent action from the Obama administration and the FDA to address increasing drug shortages could mean relief for some mesothelioma patients who rely on medications for treatment of …

View full post on mesothelioma – Yahoo! News Search Results